SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
38 hedge funds and large institutions have $97.9M invested in scPharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-8
Holders Change %
-17.39%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
4
Reduced
23
Closed
13
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
+$18K
Top Buyers
| 1 |
JGC
J. Goldman & Co
New York
|
+$3.19M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.19M |
| 3 |
Millennium Management
New York
|
+$353K |
| 4 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$226K |
| 5 |
E
Ergoteles
New York
|
+$170K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$3.26M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.37M |
| 3 |
BlackRock
New York
|
-$1.63M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.31M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.3M |
